07/11/2025
3:30 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/09/2025
11:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form EFFECT | |
07/07/2025
5:41 PM | Anderson Kelly (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2025
3:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/24/2025
3:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2025
8:29 PM | Gravitas Capital LP (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
6:31 PM | Appajosyula Sireesh (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
6:34 PM | Parikh Sanam (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2025
5:15 AM | Gravitas Capital LP (Filed by)
Hillstream BioPharma (Subject)
Tharimmune, Inc. (Subject)
| Form SCHEDULE 13D | |
06/20/2025
5:05 AM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2025
4:29 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for HILS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Hillstream BioPharma and its competitors with MarketBeat's FREE daily newsletter. |
06/10/2025
3:39 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2025
1:31 PM | GSB Holdings, Inc. (Filed by)
Hillstream BioPharma (Subject)
Tharimmune, Inc. (Subject)
| Form SCHEDULE 13G | |
05/12/2025
7:00 AM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/01/2025
9:28 AM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form ARS | |
04/30/2025
4:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form DEFA14A | |
04/30/2025
4:00 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form DEF 14A | |
04/28/2025
4:26 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2025
6:35 AM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2025
3:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2025
4:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2025
6:00 PM | Kim Dong (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/25/2025
7:12 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
01/14/2025
3:47 PM | MILBY RANDY (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:38 PM | Appajosyula Sireesh (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 424B3 | |
12/26/2024
11:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form EFFECT | |
12/20/2024
7:00 PM | MILBY RANDY (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
3:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/17/2024
3:30 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
12/06/2024
4:25 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/02/2024
3:00 PM | Parikh Sanam (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/21/2024
3:51 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
4:06 PM | Appajosyula Sireesh (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
4:22 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/10/2024
3:15 PM | MILBY RANDY (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/09/2024
8:58 AM | Appajosyula Sireesh (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4/A | |
10/08/2024
3:10 PM | Appajosyula Sireesh (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
9:00 AM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2024
8:06 AM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
4:17 PM | MILBY RANDY (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Don’t Miss This—Our Next Big Stock Pick Is Coming! (Ad) Those who recognized the opportunity early didn’t hesitate—they took action.
Now it’s your turn.
We are about to release a brand-new report featuring a company with massive breakout potential.
Here’s the best part: This report is 100% free. No hidden fees, no catch—just expert research designed to keep you ahead of the market. ➡️ Click here now to claim your free report! |
08/12/2024
4:17 PM | Bui Lynne A. (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
4:18 PM | Mazur Leonard L (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
4:18 PM | Appajosyula Sireesh (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
4:18 PM | Anderson Kelly (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
2:09 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
